Brachytherapy is considered as an internal radiation therapy for individuals undergoing treatment for endometrial cancer. It may be recommended by doctors either post-surgery or in cases where surgery is not a feasible option. The procedure and recovery period for brachytherapy can vary depending on the type being used.
There are two main types of brachytherapy used in treating endometrial cancer: low dose rate (LDR) and high dose rate (HDR). LDR brachytherapy administers lower radiation doses over an extended period of 1 to 4 days. On the other hand, HDR brachytherapy delivers a higher dose of radiation over a shorter timeframe, typically 10 to 20 minutes per session.
According to research conducted by the American Society for Radiation Oncology, vaginal brachytherapy has shown promising results in reducing the risk of endometrial cancer recurrence within the vagina. Additionally, a 2020 study indicated that a combination of external beam radiation and brachytherapy was effective in treating inoperable endometrial cancer cases.
Potential Risks and Side Effects
While brachytherapy is an effective treatment option, there are potential risks and side effects associated with it. Some of the risks include deep vein thrombosis due to prolonged immobility during treatment and radiation vaginitis, causing vaginal irritation and discomfort. Moreover, brachytherapy may lead to temporary side effects like anemia and leukopenia.
The recovery period from brachytherapy varies from person to person, with most side effects typically resolving within a few weeks to 2 months after treatment. However, some individuals may experience long-term side effects such as vaginal dryness, vaginal scar tissue, and radiation cystitis. It’s essential to consult a healthcare provider if any of these symptoms arise.
Apart from brachytherapy, individuals with endometrial cancer may also undergo treatments like progestin therapy, chemotherapy, immunotherapy, or hormone therapy based on the stage and location of cancer, tumor size, age, overall health, and individual preferences. Clinical trials testing new treatments may also be recommended for advanced cases.
Brachytherapy stands as a valuable treatment option for endometrial cancer, providing promising results in reducing cancer recurrence and improving outcomes. Despite the potential risks and side effects associated with brachytherapy, the benefits it offers in treating this type of cancer cannot be overlooked. It is crucial for individuals to weigh the pros and cons of different treatment options and work closely with their healthcare providers to determine the most suitable course of action.